Marked Reduction of LL-37/hCAP-18, an Antimicrobial Peptide, in Patients with Acute Myeloid Leukemia
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-01-15
著者
-
Ma Xiao-tong
National Laboratory Of Experimental Hematology Institute Of Hematology And Blood Diseases Hospital C
-
Lin Yong-min
National Laboratory Of Experimental Hematology Institute Of Hematology And Blood Diseases Hospital C
-
Song Yu-hua
National Laboratory Of Experimental Hematology Institute Of Hematology And Blood Diseases Hospital C
-
Wu Ke-fu
National Laboratory Of Experimental Hematology Institute Of Hematology And Blood Diseases Hospital C
-
AN Li-Li
National Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital,
-
YANG Ying-Hua
National Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital,
-
An Li-li
National Laboratory Of Experimental Hematology Institute Of Hematology And Blood Diseases Hospital C
-
Yang Ying-hua
National Laboratory Of Experimental Hematology Institute Of Hematology And Blood Diseases Hospital C
関連論文
- Marked Reduction of LL-37/hCAP-18, an Antimicrobial Peptide, in Patients with Acute Myeloid Leukemia